definiens: means Ac quired Patents, Regulatory Documentation, Regulatory Filings, technology rights, personal property, files, records, documentation, inventory, and other assets pertaining to Photrex and all other Photodynamic Therapy Technology and Photodynamic Therapy rela ted rights, programs and perfected assets acquired from Miravant by Seller, or for which Seller has rights to ownership and has not perfected such rights . The Acquired Technology includes all of Seller ’s rights in and to Miravant ’s assets including : • all contents, including all lasers, of the storage lockers located at Public Storage, 7246 Hollister Ave, Goleta, CA, lockers 4115, 4010, 4124,4113 and 173, • stents, catheters, compounds ( including SnET2, the chemical compound Tin Ethyl Etiopurpurin or any drug made from this compound ), drugs and other materials and devices used to effect Photodynamic Therapy, including the items set forth on Annex 2 ; • patents and patent applications as set forth on Annex 1, tradenames, trademarks, trademark applications, copyrights and other Intellectual Property associated with Photrex and Photodynamic Therapy, goodwill associated therewith, licenses and sublicenses g ranted and obtained with respect thereto and rights thereunder, remedies against infringements thereof, and rights to protection of interests therein under the laws of all jurisdictions, • agreements, contracts, leases, instruments, guarantees, oth er similar arrangements, and rights thereunder, • investigational new drug applications, new drug applications, regulatory filings and correspondence, franchises, approvals, permits, designations, licenses, orders, applications ( whether or not approved ), registrations, certificates, variances, and similar filings with rights obtained from governments and governmental agencies, • customer lists and other sales information, • medical, scientific, research, trial protocols ( whether or not pursued ), trial results including raw data, clinical trial data and other technical data, chemistry, manufacturing and control ( CMC ) data, toxicology and other animal preclinical data, FDA data based on filed INDs, NDAs and clinical studies and other data, 14 • product specifications, formulas, ingredients, costing, supply agreements and other product information, including stability data and records, • files, records, patient records, documents, correspondence, lists, drawings, and specifications, creati ve materials, advertising and promotional materials, studies, reports, and other printed or written materials, • inventory ( drug, consumables and equipment ) as of the Closing Date associated with Photrex and other Photodynamic Therapy programs, • all standard operating procedures and bench procedures, including ( i ) Miravant B1 -10 Bench Procedures, ( ii ) Miravant B1 -9 Bench Procedures, ( iii ) Miravant B1 -13 Specifications, ( iv ) Miravant B1 -11 SOPs for Miravant Inc., ( v ) Miravant B1 -2 SOPs for M iravant Pharmaceuticals, and ( vi ) Miravant B1 -15 BioSOP and RDP, and • Know -How, trade secrets and proprietary processes and records including, but not limited to, chemistry, manufacturing and control ( CMC ) records, medical device manufacturing pro cesses, non -clinical and clinical pharmacology, toxicology and safety records and clinical case report form ( CRF ) records relevant to cancer applications and regulatory filings